📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. (2020)

First Author: Gorman E

Attributed to: A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04416-w

PubMed Identifier: 32493473

Publication URI: http://europepmc.org/abstract/MED/32493473

Type: Journal Article/Review

Volume: 21

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215